Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Take a look at 3 month chart. We are building back up.
Mickey Gains, that you?
Absolutely. Once series b and warrants get eaten up, together w a (fingers crossed) good ER, we should move up nicely.
Hope she waits until tmrw to really run
Nice. Carry on.
Or was he just pointing out details of the job description....?
What is the connection between aramark and Amedica??
Can someone please remind me, when is the deadline to regain compliance w listing req?
How does creating another listing issue for AMDA benefit someone looking to buy them out? Greater negotiating power?
Seems like reversal
Float listed on iHub is wrong, no? Is much higher than 11 mil....
Deal or no deal, I can almost guarantee you the co. will effect a RS.
Also, if we get BO for 6 dollars per share, I will be very, very surprised.
Aldox isn't a wonder drug. It's an old drug w a better delivery system. As far as pps goes, despite the enticing tidbits the company has come out w to date, the market is still in the dark as to what kind of data they will present at ASCO. Might be worth a BO by BP, might not.
If warrant conversion is done, why is the stock sitting at sub .1?
Honest inquiry, thanks in advance.
Indeed.
This thing can't stay down forever. Unfortunately, I do not foresee any massive pumps like those that happened last year, given that practically all of the cards are now on the table, so to speak.
I dunno. Do you see this getting back into the 50s by April?
At this rate we will reach .3 by next Friday.
Thanks for this chemist, nice work.
I really think you are being a bit paranoid. While anything is possible, seems to me that current sp is reflective of a few things, namely, hesitation to jump in until deal is inked, shitty sales of addy, and warrant scheme. Thoughts?
God I hope soon.
I respect what you are saying, but it's not like prescribing Vicodin for pink eye. Brem was initially tested as an ED drug, and it worked like gangbusters, but the trials were discontinued due to high blood pressure. This, however, was deemed to be caused by the way the drug was administered, as a nasal spray.
I enjoy the discussion though. Do you currently own any PTN?
Hey RFB, why don't you take a breath. Stocker makes a valid assumption. There is nothing intrinsic to the drug's MOA that says "works better on females" ... in fact, i'd be willing to bet that once this hits the market, couples will experiment, word will get out, and brem will ultimately become a blockbuster.
So I have been learning quite a bit about warrants as of late. ST user Nugtordust lays it out pretty well. Apparently, the prefunded, 0.01 warrants were purchased for .50 each. So it really does not make sense that they would be exercised below that price. They could be, given that they have a strike price of 0.01 ... but that would = a loss for the warrant holder.
Looks like approx 41m expire in 2022, another 25m in 2024, and the last batch of ~ 22m expire in 2025.
Warrants
Anyone who read the latest filing know how many are left? Ballpark?
Are you drunk?
Keep pulling the sweater ... eventually the whole thing will unravel.
Indeed. Thanx. I was curious to get someone else's take, as that is the first time I have seen an insider trade posted to iHub.
Insider B/S:
Anybody notice that (according to IHUB anyway) ~1/2 million insider shares were traded today?
Thoughts?
lol. Indeed!
Seasoned's 4 point assessment is right on the money.
In addition, I would add
5. fear vis-a-vis the method of administration i.e. auto injector.
This sentiment is, IMO, naive to say the least. When considering the target population, and that BMT--which activates dopamine release for Christsake!--has been proved effective, such a concern is quickly seen for what it is: rubbish.
I believe he said early Q4 ... not early October